Literature DB >> 1310183

RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3.

M S Galinski1, R M Troy, A K Banerjee.   

Abstract

RNA editing of the human parainfluenza virus type 3 (HPIV3) phosphoprotein (P) gene was found to occur for the accession of an alternate discontinuous cistron. Editing occurred within a purine-rich sequence (AAUUAAAAAAGGGGG) found at the mRNA nucleotides 791-805. This sequence resembles an HPIV3 consensus transcription termination sequence and is located at the 5'-end of the putative D protein coding sequences. Editing at an alternate site (AAUUGGAAAGGAAAGG), mRNA nucleotides 1121-1136, for accession of a conserved V cistron, which is present in a number of paramyxovirus P genes, was not found to occur in HPIV3. In contrast with many other paramyxoviruses, editing was indiscriminate with the insertion of 1-12 additional G residues not present in the gene template. RNA editing was found to occur in both in vivo (HPIV3 infected cells) and in vitro (purified nucleocapsid complexes) synthesized mRNAs. Further, the in vitro prepared mRNA was edited regardless of whether the nucleocapsid complexes were transcribed in the presence or absence of uninfected human lung carcinoma (HLC) cell lysates. These results support the notion that RNA editing appears to be exclusively a function of viral proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310183      PMCID: PMC7130814          DOI: 10.1016/0042-6822(92)90020-p

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3.

Authors:  B P De; M S Galinski; A K Banerjee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Sequence analysis of the P and C protein genes of human parainfluenza virus type 3: patterns of amino acid sequence homology among paramyxovirus proteins.

Authors:  M K Spriggs; P L Collins
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

3.  A comprehensive sequence analysis program for the IBM personal computer.

Authors:  C Queen; L J Korn
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Sendai virus contains overlapping genes expressed from a single mRNA.

Authors:  C Giorgi; B M Blumberg; D Kolakofsky
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  Sequence analysis of the phosphoprotein (P) genes of human parainfluenza type 4A and 4B viruses and RNA editing at transcript of the P genes: the number of G residues added is imprecise.

Authors:  K Kondo; H Bando; M Tsurudome; M Kawano; M Nishio; Y Ito
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

7.  Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex.

Authors:  M Hamaguchi; T Yoshida; K Nishikawa; H Naruse; Y Nagai
Journal:  Virology       Date:  1983-07-15       Impact factor: 3.616

8.  Comparison of sequence diversity in several cytoplasmic polyhedrosis viruses.

Authors:  M S Galinski; V H Stanik; G F Rohrmann; G S Beaudreau
Journal:  Virology       Date:  1983-10-30       Impact factor: 3.616

9.  The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site.

Authors:  T Pelet; J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

10.  Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot.

Authors:  I Brierley; P Digard; S C Inglis
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

View more
  33 in total

1.  Chemical modification of nucleotide bases and mRNA editing depend on hexamer or nucleoprotein phase in Sendai virus nucleocapsids.

Authors:  Frédéric Iseni; Florence Baudin; Dominique Garcin; Jean-Baptiste Marq; Rob W H Ruigrok; Daniel Kolakofsky
Journal:  RNA       Date:  2002-08       Impact factor: 4.942

2.  Identification of simian agent 10 as human parainfluenza virus type 3 suggests transmission of a human virus to an African monkey.

Authors:  Sachin Kumar; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2010-09-29       Impact factor: 5.103

3.  A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.

Authors:  J E Bailly; J M McAuliffe; A P Durbin; W R Elkins; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; Y Nagai
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

5.  Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.

Authors:  T Tao; A P Durbin; S S Whitehead; F Davoodi; P L Collins; B R Murphy
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals.

Authors:  L F Wang; W P Michalski; M Yu; L I Pritchard; G Crameri; B Shiell; B T Eaton
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; T Shioda; Y Nagai
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Nipah virus edits its P gene at high frequency to express the V and W proteins.

Authors:  Sachin Kulkarni; Valentina Volchkova; Christopher F Basler; Peter Palese; Viktor E Volchkov; Megan L Shaw
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.

Authors:  Samer Swedan; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.